5 Low Risk High Reward Stocks Set To Triple By 2027

3. ImmunoGen, Inc. (NASDAQ:IMGN)

Number of Hedge Fund Investors In Q2 2023: 42

ImmunoGen, Inc. (NASDAQ:IMGN) is a biotechnology company that is focusing on developing treatments for cancer patients. Its shares are rated Strong Buy on average and analysts have penned in a $8 share price upside on the current price of $15 based on the average share price.

After digging through 910 hedge fund holdings for their June quarter of 2023 investments, Insider Monkey found that 42 had invested in ImmunoGen, Inc. (NASDAQ:IMGN). Jeremy Green’s Redmile Group is the company’s largest stakeholder through its $334 million investment.

Follow Immunogen Inc. (NASDAQ:IMGN)